Lupus News Corner News and Stories BIG … BOLD … IDEAS ARE TRANSFORMING LUPUS RESEARCH—thanks to people like you! Thanks to our remarkable supporters, the Lupus...
Antioxidant Defenses News and Stories Antioxidant defenses are compounds that inhibit oxidation—oxidation that can trigger the production of free radicals. Free radical activity...
New LRA-Supported Study Provides Clue to Potential New Treatment Target News and Stories February 27, 2020 A new study supported by the Lupus Research Alliance discovered that molecules called type II interferons can...
Lupus Therapeutics Collaborating with PPD to Accelerate Lupus Clinical Research News and Stories September 3, 2020 PPD, Inc. issued a press release today announcing its collaboration with the Lupus Research Alliance affiliate Lupus...
Edema News and Stories Edema means swelling caused by excess fluid in the body's tissues. It usually occurs in the feet, ankles and...
Advocacy Update: 2025 Continuing Resolution Approved News Update Thank you to all advocates who reached out to your congressional office to express your support for continued lupus...
Lupus Research Alliance Launches Clinical Trial Network Press Release NEW YORK, NY. October 16, 2019 — The Lupus Research Alliance today announced the launch of a the Lupus Clinical Investigators Network (LuCIN)to...
Drug-Induced Lupus (DIL) News and Stories Drug-induced lupus erythematosus (DILE) is a lupus-like syndrome temporally related to continuous drug exposure which resolves upon drug discontinuation. Source:...
Novel Therapeutic Approaches & Translational Challenges News and Stories One session at our recent scientific conference Forum for Discovery was devoted to meeting the need for new approaches...
Overcoming Challenges to Lupus Management News and Stories January 24, 2019 A recent review article in Lupus Science & Medicine provides a valuable overview of the “10 most...